Your browser doesn't support javascript.
loading
A Benefit-Risk Analysis Approach to Capture Regulatory Decision-Making: Non-Small Cell Lung Cancer.
Raju, G K; Gurumurthi, K; Domike, R; Kazandjian, D; Blumenthal, G; Pazdur, R; Woodcock, J.
  • Raju GK; Light Pharma, Inc., Cambridge, Massachusetts, USA.
  • Gurumurthi K; Light Pharma, Inc., Cambridge, Massachusetts, USA.
  • Domike R; Light Pharma, Inc., Cambridge, Massachusetts, USA.
  • Kazandjian D; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.
  • Blumenthal G; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.
  • Pazdur R; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.
  • Woodcock J; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.
Clin Pharmacol Ther ; 100(6): 672-684, 2016 12.
Article en En | MEDLINE | ID: mdl-27617424
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Aprobación de Drogas / Carcinoma de Pulmón de Células no Pequeñas / Toma de Decisiones / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Etiology_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Humans País como asunto: America do norte Idioma: En Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Aprobación de Drogas / Carcinoma de Pulmón de Células no Pequeñas / Toma de Decisiones / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Etiology_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Humans País como asunto: America do norte Idioma: En Año: 2016 Tipo del documento: Article